Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

Monday’s Trading Day
1.13 +0.05 / +4.63%
As of Oct 05
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
1.18 +0.05 / +4.42%
Volume: 755.00
Health Technology

Company Description

Athersys, Inc. operates as a biopharmaceutical company, which is engaged in the discovery and development of therapies designed to extend and enhance the quality of human life. It establishes product development programs through the application of proprietary technologies in the field of regenerative medicine. The company's product development program, MultiStem, a proprietary off the shelf stem cell product used to treat indications in the inflammatory & immune, neurological and cardiovascular disease areas. Athersys was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Contact Information

Athersys, Inc.
3201 Carnegie Avenue
Cleveland Ohio 44115-2634
P:(216) 431-9900
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Gil van BokkelenChairman & Chief Executive Officer
William B. J. LehmannPresident, Chief Operating Officer & Secretary
Laura K. CampbellVice President-Finance
John J. HarringtonDirector, Chief Scientific Officer & Executive VP
Manal MorsyVice President & Head-Global Regulatory Affairs